Kadmon Holdings, Inc. Made Headway

Kadmon Holdings, Inc. (KDMN:NASDAQ) rocketted at $4.28, a gain of 20.6%. On Thu, Jul 15, 2021, KDMN:NASDAQ hit a New 2-Week Low of $3.55. The stock appeared on our News Catalysts scanner on Fri, Jul 16, 2021 at 04:44 PM in the 'BIOTECH' category. From Thu, Jul 01, 2021, the stock recorded 11.11% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kadmon Holdings, Inc. (KDMN:NASDAQ)
Kadmon Holdings Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases.
Top 10 Gainers:
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 41.33%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Aehr Test Systems (AEHR:NASDAQ), 21%
- Kadmon Holdings, Inc. (KDMN:NASDAQ), 20.56%
- BON (BON:NASDAQ), 18.96%
- NEGG (NEGG:NASDAQ), 16.6%
- IKNA (IKNA:NASDAQ), 13.34%
- Weidai Ltd. (WEI:NYSE), 12.84%
- ELYS (ELYS:NASDAQ), 12.81%
- RPID (RPID:NASDAQ), 12.62%